Navigation Links
Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
Date:6/24/2009

Study shows 4% CHG antiseptic is effective against a strain of H1N1 Swine Flu

NORCROSS, Ga., June 24 /PRNewswire/ -- Hand washing with a 4% chlorhexidine gluconate (CHG) antiseptic hand washing product is one effective way to stop the spread of the H1N1 Swine Flu Virus.

Hibiclens Antiseptic/Antimicrobial Skin Cleanser and Hibistat Healthcare Personnel Hand Antiseptic Towelettes have been tested and found to be effective against a variation of the A H1N1 Swine Flu Virus, when used according to package instructions. The strain tested was Swine Flu Influenza A H1N1 A/Swine/Iowa/15/3.

The time-kill study, conducted by an independent laboratory showed that Hibiclens(R), a 4% CHG product, reduced the virus by 99.94 percent after 30 second, 60 second, and three minute exposures. Hibistat(R), a 0.5% CHG and 70% isopropyl alcohol formulation, reduced the virus by 99.99 percent after 15 second, 30 second and 60 second exposures. Both Hibiclens and Hibistat were more effective than soap and water which was used as a comparator test product.

"With any type of influenza outbreak, managing the spread of virus is the biggest concern," said Carolyn Twomey, RN, Global Head of Clinical Services, Molnlycke Health Care. "Influenza viruses usually spread via sneezing and coughing and contaminating one's hand or hands, and then touching surfaces, shaking hands or other contact behaviors. With any influenza outbreak, good hand hygiene is extremely important. With the current strains of flu virus, this study shows that washing with Hibiclens or using Hibistat Hand Wipes provides additional benefit in preventing transmission."

"Use of Molnlycke Health Care's Hibiclens and Hibistat antimicrobial/antiseptic products, along with the company's line of surgical facemasks and respirators, can be an integral part of a protocol to reduce the risk of cross-contamination," Twomey said.


'/>"/>
SOURCE Molnlycke Health Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
2. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
3. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
4. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
5. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DuPont Provides Technology for Washington Hospital Centers Emergency Department
10. Top Washington Health Officials to Honor Framingham Heart Study Participants
11. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/-...peciallythe27millionlivingwithuntreated hearinglos...CindyBeyer. ,, Dr.Beyer,seniorvicepresidentofHe...and hearingaids companies,saidstudieshavelinkedhea...hichcaneasilybeintensifiedatholidaygatheringswithf...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comanno...atalogue: ,, UnitedStatesDentalDevicesMarketAn...linker.com/p0158733/United-States-Dental-Devices-M...nitedStatesDentalDevicesMarketAnalysisandForecasts...alsourceforin-depthinformationanddatarelatingtothe...
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,...developingproductsforminimallydisruptivesurgicaltr...onferencecallonMonday,November30,2009,at5:30p.m.ET...uesrelativetoreimbursementfortheCompany,sproductsa...tquestionandanswersession.Thedial-innumbersare1-87...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 1MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 2MedicAlert Foundation to Offer 24 Hour Emergency Medical Information Services for Deaf Community Services of San Diego Inc 58721 3Vital Therapies Initiates Liver Stabilization Trial 58719 1Vital Therapies Initiates Liver Stabilization Trial 58719 2Operation Smile to Honor the Simpson Family Stephen Berman the Honorable Richard J Riordan Roselyn Sanchez and Eric Winter at 8th Annual Smile Gal 58717 1Operation Smile to Honor the Simpson Family Stephen Berman the Honorable Richard J Riordan Roselyn Sanchez and Eric Winter at 8th Annual Smile Gal 58717 2
...lts for,Keppra® as Adjunctive Therapy for Part... Month to Less than Four Years of,Age , BRUSSELS, ...itive top-line results from a phase III, double-bl...study evaluating the,efficacy and tolerability of ...djunctive therapy in the treatment of partial onse...
...7 - Affymax, Inc.,(Nasdaq:AFFY) today announced re...rials of Hematide(TM) in dialysis and,non-dialysis...howed,that in treatment naive, non-dialysis patien... monthly at an appropriate dose.,Similarly, the da...ree-times weekly Epoetin Alfa demonstrated that me...
Other Medicine Technology:UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 2Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease 3
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)...25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,In...osttwoinvestoreventsinDecember: ,, ASHBriefin... ,, Principalinvestigatorswilldiscussdataprese...actorymultiplemyeloma,asfeaturedatthe51stAmericanS...nNewOrleans,LA.Theteleconferencewillbeginat9:00a.m...
(Date:11/25/2009)...5/PRNewswire-USNewswire/--AnarticlebyJanetWoodcock...Research,titled"ADifficultBalance-PainManagement,D...fTheNewEnglandJournalofMedicine. ,, (Logo: http... ,, Inthearticle,WoodcockdiscussesFDAeffortstos...whoneeditandmanagingtherisksposedbyvariousanalgesi...
(Date:11/25/2009)...cular cancer who were treated with cisplatin-based...ing neurological side effects and Raynaud-like phe...erapy, according to a new study published online N...Institute . , Marianne Brydy, M.D., of the Depar...in Bergen, Norway, and colleagues conducted a cros...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...reduce Alzheimer's disease, says a study on mice, ...ed if the findings apply to people.// Jun Wan...School of Medicine studied female mice with genes ...ce magazine WebMD. The researchers split the...
...discover an effective method of vaccinating mice a...pestis//, with the details of their study publishe...gy. Egil Lien and his colleagues at the Univers...in the development of an effective vaccine method....
... have developed a new strain of mice that should h... contributes to a particularly deadly form of acut...train by its developers at the Ohio State Universi...ps govern blood cell development. The genet...
...s of kidney cancer has been rising over the last t...f Michigan Comprehensive Cancer Center shows// tha... of small, presumably curable, kidney masses. But ...With increased early detection and treatment of sm...
...eals that short sessions (a few minutes a day) of ... as moderate exercises done for hours//. Marti... McMaster University and his team conducted this s...m our study was the remarkably similar improvement...
...ion has announced that it will be conducting a dri... and NGO representatives will visit areas in the//...e in waste bins, bottles and cans. Mayor Mer... The State chapter of the Indian Medical Assoc...
Other Medicine News:Health News:Mouse Gene With Gene Stutter Will Help Leukemia Research 2Health News:Mouse Gene With Gene Stutter Will Help Leukemia Research 3Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 2Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 3
5 mm and 10 mm Laparoscopy Instrument Repair and Reinsulation
...er optics reduce the light output to your surgical...ptical clarity that is so vital. Frequent inspecti...l to prevent further damage and more extensive and...echnician can inspect your cables for you at no ch...
Rigid Endoscope Repair
...inspects your equipment upon arrival. Our technici...ovides you with a thorough customer quote. We resp...so well help you prioritize repairs. With customer... , ISI uses only OEM or widely approved equivale...
Medicine Products: